inveox automates pathology labs to prevent cancer misdiagnosis and improve lab efficiency.
inveox has raised €17M across 1 funding round, most recently a Series A round in Oct 2019. Based in Garching Bei München, Germany; founded 2017; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-10-01 | Series A | €17M |
| — |
| View deal → |
